Regent Investment Management LLC Abb Vie Inc. Transaction History

Regent Investment Management LLC

$373 Million
Q4 2022

A detailed history of Regent Investment Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Regent Investment Management LLC holds 20,488 shares of ABBV stock, worth $3.99 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

20,488

Previous 20,588 0.49%

Holding current value

$3.99 Million

Previous $2.76 Million 19.83%

% of portfolio

0.89%

Previous 0.81%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $13,831 - $16,587	-100 Reduced 0.49%	20,488 $3.31 Million
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $3,355 - $3,848	25 Added 0.12%	20,588 $2.76 Million
Q2 2022 Jul 15, 2022	SELL	$137.62 - $174.96 $125,784 - $159,913	-914 Reduced 4.26%	20,563 $3.15 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $127,624 - $158,346	-967 Reduced 4.31%	21,477 $3.48 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $23,312 - $29,496	217 Added 0.98%	22,444 $3.04 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $98,845 - $112,204	929 Added 4.36%	22,227 $2.4 Million
Q2 2021 Jul 16, 2021	SELL	$105.21 - $117.21 $25,250 - $28,130	-240 Reduced 1.11%	21,298 $2.4 Million
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $134,013 - $147,532	1,310 Added 6.48%	21,538 $2.33 Million
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $1.63 Million - $2.2 Million	20,228 New	20,228 $2.17 Million
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $1.77 Million - $2.08 Million	-20,620 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $323,121 - $432,384	4,404 Added 27.16%	20,620 $2.03 Million
Q1 2020 Apr 17, 2020	SELL	$64.5 - $97.79 $52,567 - $79,698	-815 Reduced 4.79%	16,216 $1.24 Million
Q4 2019 Jan 30, 2020	SELL	$72.13 - $90.25 $182,849 - $228,783	-2,535 Reduced 12.96%	17,031 $1.51 Million
Q3 2019 Oct 17, 2019	SELL	$62.98 - $75.72 $82,818 - $99,571	-1,315 Reduced 6.3%	19,566 $1.48 Million
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $58,626 - $69,000	-760 Reduced 3.51%	20,881 $1.68 Million
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $60,333 - $74,407	775 Added 3.71%	21,641 $2 Million
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $668,158 - $742,782	7,515 Added 56.29%	20,866 $1.97 Million
Q2 2018 Jul 16, 2018	BUY	$89.78 - $106.23 $9,516 - $11,260	106 Added 0.8%	13,351 $1.24 Million
Q1 2018 Apr 24, 2018	BUY	$92.01 - $123.21 $9,201 - $12,321	100 Added 0.76%	13,245 $1.25 Million
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $16,747 - $18,365	187 Added 1.44%	13,145 $1.27 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $905,116 - $1.16 Million	12,958	12,958 $1.15 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.

Account

Regent Investment Management LLC Abb Vie Inc. Transaction History